AAAAAA

   
Results: 1-3 |
Results: 3
Phase I pharmacokinetic trial and correlative in vitro phase II tumor kinetic study of apomine (SR-45023A), a novel oral biphosphonate anticancer drug
Authors: Alberts, DS Hallum, AV Stratton-Custis, M Garcia, DJ Gleason-Guzman, M Salmon, SE Santabarbara, P Niesor, EJ Floret, S Bentzen, CL
Citation: Ds. Alberts et al., Phase I pharmacokinetic trial and correlative in vitro phase II tumor kinetic study of apomine (SR-45023A), a novel oral biphosphonate anticancer drug, CLIN CANC R, 7(5), 2001, pp. 1246-1250
Laminin-5-mediated gene expression in human prostate carcinoma cells
Authors: Calaluce, R Kunkel, MW Watts, GS Schmelz, M Hao, JS Barrera, J Gleason-Guzman, M Isett, R Fitchmun, M Bowden, GT Cress, AE Futscher, BW Nagle, RB
Citation: R. Calaluce et al., Laminin-5-mediated gene expression in human prostate carcinoma cells, MOL CARCINO, 30(2), 2001, pp. 119-129
cDNA microarray analysis of multidrug resistance: Doxorubicin selection produces multiple defects in apoptosis signaling pathways
Authors: Watts, GS Futscher, BW Isett, R Gleason-Guzman, M Kunkel, MW Salmon, SE
Citation: Gs. Watts et al., cDNA microarray analysis of multidrug resistance: Doxorubicin selection produces multiple defects in apoptosis signaling pathways, J PHARM EXP, 299(2), 2001, pp. 434-441
Risultati: 1-3 |